Singapore markets close in 4 hours 41 minutes
Straits Times Index
3,375.29 +11.61 (+0.35%) Nikkei
27,504.42 +102.37 (+0.37%) Hang Seng
21,562.34 -396.02 (-1.80%) FTSE 100
7,820.16 +59.05 (+0.76%) BTC-USD
23,534.71 -333.22 (-1.40%) CMC Crypto 200
536.51 -8.80 (-1.61%)
SpringWorks Therapeutics, Inc. (SWTX)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EST
After hours:
| Previous close | 31.88 |
| Open | 32.52 |
| Bid | 24.10 x 900 |
| Ask | 41.96 x 1000 |
| Day's range | 31.89 - 34.15 |
| 52-week range | 13.60 - 65.92 |
| Volume | |
| Avg. volume | 751,960 |
| Market cap | 2.124B |
| Beta (5Y monthly) | 0.57 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -4.23 |
| Earnings date | 22 Feb 2023 - 27 Feb 2023 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 65.33 |
- Zacks
SpringWorks (SWTX) Down Despite Desmoid Tumors Study Meeting Goal
SpringWorks' (SWTX) phase III study evaluating its investigational candidate, nirogacestat, in adult patients with progressing desmoid tumors, meets primary and key secondary endpoints.
- Zacks
Allogene (ALLO) Focuses on Pipeline Amid Lack of Marketed Drugs
With no product revenues due to the lack of marketed drugs, Allogene (ALLO) focuses on developing its pipeline candidates that mainly consist of allogenic CAR T therapies.
© 2023 Yahoo. All rights reserved.
